Cleveland BioLabs
11:05 :
Cleveland BioLabs tanks on funding update -
BOSTON (MarketWatch) -- Cleveland BioLabs shares dove 35% to $1.55 on Wednesday, the day after it announced that a division of the U.S. Department of Health and Human Services was no longer interested in providing funding for ...
05:44 :
Cleveland BioLabs awarded $5M grant -
A Buffalo biotech firm has received a $5 million grant from the Russian government to support cancer research. Incuron LLC, a joint venture between Cleveland BioLabs Inc. (NASDAQ: CBLI) and a Russian-based venture capital fund, ...
actualidad Cleveland BioLabs -